Start › Rak prostaty › Kalifornia › San Francisco
Badania kliniczne dla Rak prostaty w mieście San Francisco, CA
45 badań dla Rak prostaty szuka uczestników w ośrodkach w mieście San Francisco i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RekrutacjaFaza 3
- Kaiser Permanente-San Francisco, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
Rekrutacja
- Kaiser Permanente-San Francisco, San Francisco
Precision-Based Genomics in Prostate Cancer
RekrutacjaBadanie obserwacyjne
- University of California San Francisco, San Francisco
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RekrutacjaFaza 3
- San Francisco VA Health Care System ( Site 0093), San Francisco
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
RekrutacjaFaza 3
- University of California San Francisco, San Francisco
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Rekrutacja
- University of California San Francisco, San Francisco
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekrutacjaFaza 3
- Kaiser Permanente-San Francisco, San Francisco
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
RekrutacjaFaza 2
- University of California, San Francisco, San Francisco
Prostate Active Surveillance Study
RekrutacjaBadanie obserwacyjne
- Veterans Affairs San Francisco Health Care System, San Francisco
- University of California, San Francisco, San Francisco
A Study of Tarlatamab for People With Prostate Cancer
RekrutacjaFaza 2
- University of California San Francisco, San Francisco
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
RekrutacjaFaza 1
- University of California, San Francisco, San Francisco
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
RekrutacjaBadanie obserwacyjne
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
RekrutacjaFaza 3
- Research Site, San Francisco
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
RekrutacjaFaza 1
- University of California San Francisco, San Francisco
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
RekrutacjaFaza 2
- University of California San Francisco, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RekrutacjaFaza 1
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
RekrutacjaFaza 1/2
- Research Site, San Francisco
A Study of DM002 in Patients With Advanced Solid Tumors
RekrutacjaFaza 1/2
- University of California San Francisco Cancer Center, San Francisco
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
RekrutacjaFaza 1
- University of California San Francisco, San Francisco
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
RekrutacjaFaza 1/2
- University of California, San Francisco, San Francisco
PSMA PET Combined With MRI for the Detection of PCa
RekrutacjaFaza 3Zapraszamy zdrowych ochotników
- University of California San Francisco, San Francisco
Imaging of Solid Tumors Using 18F-TRX
RekrutacjaFaza 1
- University of California, San Francisco, San Francisco
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RekrutacjaFaza 1
- University of California San Francisco, San Francisco
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities
RekrutacjaBadanie obserwacyjne
- University of California, San Francisco, San Francisco
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
RekrutacjaFaza 2
- University of California San Francisco, San Francisco
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
RekrutacjaFaza 1
- University of California San Francisco, San Francisco
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
RekrutacjaFaza 2
- University of California, San Francisco, San Francisco
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
RekrutacjaFaza 1
- University of California, San Francisco, San Francisco
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
RekrutacjaFaza 2
- University of California, San Francisco, San Francisco
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- University of California, San Francisco, San Francisco
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
Rekrutacja
- UCSF, San Francisco
Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer
RekrutacjaWczesna faza 1
- University of California, San Francisco, San Francisco
Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer
Rekrutacja
- University of California, San Francisco
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
RekrutacjaFaza 3
- Kaiser Permanente-San Francisco, San Francisco
Mechanisms of Resistance to PSMA Radioligand Therapy
RekrutacjaBadanie obserwacyjne
- University of California, San Francisco, San Francisco
64Cu-GRIP B in Patients With Advanced Malignancies
RekrutacjaFaza 1/2
- University of California, San Francisco, San Francisco
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer
Rekrutacja
- San Francisco Veterans Affairs Medical Center, San Francisco
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RekrutacjaFaza 1/2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekrutacjaFaza 1
- University of California San Francisco, San Francisco
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
RekrutacjaFaza 2
- University of California, San Francisco, San Francisco
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
Rekrutacja
- Zuckerberg San Francisco General Hospital, San Francisco
- San Francisco Veterans Administration Medical Center, San Francisco
- University of California San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekrutacjaBadanie obserwacyjne
- Massive Bio SYNERGY-AI site, San Francisco
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RekrutacjaFaza 3
- Kaiser Permanente-San Francisco, San Francisco
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
RekrutacjaBadanie obserwacyjne
- University of California, San Francisco, San Francisco
Badania dla Rak prostaty w innych miastach
- New York City, NY103 badań
- Houston, TX76 badań
- Los Angeles, CA61 badań
- Boston, MA59 badań
- St. Louis, MO46 badań
- Chicago, IL45 badań
- Philadelphia, PA44 badań
- Baltimore, MD43 badań
- Nashville, TN42 badań
- Seattle, WA42 badań
- Washington, DC38 badań
- Dallas, TX36 badań
Inne badania w mieście San Francisco
- Rak piersi43 badań
- Niedrobnokomórkowy rak płuca36 badań
- Nowotwory (wszystkie typy)35 badań
- Niewydolność serca29 badań
- Nowotwór przerzutowy28 badań
- Rak płuc23 badań
- Czerniak22 badań
- Rak trzustki20 badań
- Rak jajnika19 badań
- Rak jelita grubego i odbytnicy18 badań
- Choroby układu sercowo-naczyniowego18 badań
- Glejak wielopostaciowy17 badań
Źródło: ClinicalTrials.gov, dane pobrane 5 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.